1679.9000 3.60 (0.21%)
NSE Jul 07, 2025 15:31 PM
Volume: 1.6M
 

1679.90
0.21%
Sun Pharma may incur revenue loss for ransomware incident on March 2
Business Standard
Sun Pharma Advanced Research Company may incur expenses in connection with incident; India was the second most attacked country for ransomware in the APAC-Japan region in 2022
More from Sun Pharmaceutical Industries Ltd.
Recommended